$19.51
0.36% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US6901451079
Symbol
OM

Outset Medical Inc Stock price

$19.51
+9.53 95.49% 1M
+8.62 79.23% 6M
+2.86 17.18% YTD
-34.64 63.97% 1Y
-331.79 94.45% 3Y
-890.69 97.86% 5Y
-890.69 97.86% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.07 0.36%
ISIN
US6901451079
Symbol
OM
Sector

Key metrics

Market capitalization $70.10m
Enterprise Value $-16.89m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.17
EV/Sales (TTM) EV/Sales -0.15
P/S ratio (TTM) P/S ratio 0.61
P/B ratio (TTM) P/B ratio 2.08
Revenue growth (TTM) Revenue growth -7.84%
Revenue (TTM) Revenue $115.27m
EBIT (operating result TTM) EBIT $-91.46m
Free Cash Flow (TTM) Free Cash Flow $-96.74m
Cash position $189.00m
EPS (TTM) EPS $-29.22
P/E forward negative
P/S forward 0.57
EV/Sales forward negative
Short interest 6.41%
Show more

Is Outset Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Outset Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Outset Medical Inc forecast:

3x Buy
60%
2x Hold
40%

Analyst Opinions

5 Analysts have issued a Outset Medical Inc forecast:

Buy
60%
Hold
40%

Financial data from Outset Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
115 115
8% 8%
100%
- Direct Costs 74 74
22% 22%
64%
41 41
35% 35%
36%
- Selling and Administrative Expenses 97 97
26% 26%
84%
- Research and Development Expense 30 30
46% 46%
26%
-86 -86
45% 45%
-75%
- Depreciation and Amortization 5.56 5.56
15% 15%
5%
EBIT (Operating Income) EBIT -91 -91
44% 44%
-79%
Net Profit -114 -114
33% 33%
-99%

In millions USD.

Don't miss a Thing! We will send you all news about Outset Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Outset Medical Inc Stock News

Neutral
GlobeNewsWire
7 days ago
SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of healthcare industry veteran Kevin O'Boyle to its Board of Directors and as chair of its Audit Committee. With Mr. O'Boyle's appointment, the compan...
Neutral
GlobeNewsWire
12 days ago
SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 20, 2025, at 10:30 a.m. Eastern time.
Neutral
Seeking Alpha
13 days ago
Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript
More Outset Medical Inc News

Company Profile

Outset Medical, Inc. is a medical technology company, which provides dialysis solutions to patients and healthcare providers. Its product Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Head office United States
CEO Leslie Trigg
Founded 2003
Website www.outsetmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today